Purpose/ObjectiveTo evaluate complications after radiosurgery of meningiomas, investigate predicative factors, and compare these risks to radiosurgery of arteriovenous malformations (AVM).Materials/MethodsFrom 1987–1992, 435 meningiomas were managed with Gamma knife radiosurgery at the University of Pittsburgh to a median marginal tumor dose of 15 Gy (range: 8.9–25); a median treatment volume of 5.1 cc (range: 0.47–56.5), and a median maximum dose of 30 Gy (range: 18–50). Median follow up was 33 months (range: 2–164 months). Tumors were treated after subtotal resection in 189 patients and for recurrence after total resection in 26 patients. 56 were associated with NF2. 296 were female and 139 male. A group of 193 AVM radiosurgery patients with >2yr follow-up was used to compare risks of radiation sequelae.ResultsSymptomatic sequelae developed in 21 patients for an actuarial rate of 6.6±1.4 % at 5 years. There were 15 cases of symptomatic parenchymal injury or edema (4.04±1.04%), including 3 patients requiring shunts, and 8 new cranial nerve deficits (2.69±0.95%). Asymptomatic post-radiosurgery imaging changes were identified on follow-up imaging in 15 patients (4.26±1.09%). Multivariate analysis significantly correlated symptomatic sequaelae with 12-Gy volume, isodose, and marginal dose (p = 0.0072, 0.005, 0.0486), while parenchymal injury (excluding cranial neuropathies) correlated with volume and age (p = 0.0007, 0151). When complication risk in 276 of these meningioma patients with >2 yr follow-up were compared to 193 AVM patients in a multivariate model including dose and volume, the risk of symptomatic sequelae was 2.58 times higher for the AVM patients (p = 0.0415) (Table).Conclusions Purpose/ObjectiveTo evaluate complications after radiosurgery of meningiomas, investigate predicative factors, and compare these risks to radiosurgery of arteriovenous malformations (AVM). To evaluate complications after radiosurgery of meningiomas, investigate predicative factors, and compare these risks to radiosurgery of arteriovenous malformations (AVM). Materials/MethodsFrom 1987–1992, 435 meningiomas were managed with Gamma knife radiosurgery at the University of Pittsburgh to a median marginal tumor dose of 15 Gy (range: 8.9–25); a median treatment volume of 5.1 cc (range: 0.47–56.5), and a median maximum dose of 30 Gy (range: 18–50). Median follow up was 33 months (range: 2–164 months). Tumors were treated after subtotal resection in 189 patients and for recurrence after total resection in 26 patients. 56 were associated with NF2. 296 were female and 139 male. A group of 193 AVM radiosurgery patients with >2yr follow-up was used to compare risks of radiation sequelae. From 1987–1992, 435 meningiomas were managed with Gamma knife radiosurgery at the University of Pittsburgh to a median marginal tumor dose of 15 Gy (range: 8.9–25); a median treatment volume of 5.1 cc (range: 0.47–56.5), and a median maximum dose of 30 Gy (range: 18–50). Median follow up was 33 months (range: 2–164 months). Tumors were treated after subtotal resection in 189 patients and for recurrence after total resection in 26 patients. 56 were associated with NF2. 296 were female and 139 male. A group of 193 AVM radiosurgery patients with >2yr follow-up was used to compare risks of radiation sequelae. ResultsSymptomatic sequelae developed in 21 patients for an actuarial rate of 6.6±1.4 % at 5 years. There were 15 cases of symptomatic parenchymal injury or edema (4.04±1.04%), including 3 patients requiring shunts, and 8 new cranial nerve deficits (2.69±0.95%). Asymptomatic post-radiosurgery imaging changes were identified on follow-up imaging in 15 patients (4.26±1.09%). Multivariate analysis significantly correlated symptomatic sequaelae with 12-Gy volume, isodose, and marginal dose (p = 0.0072, 0.005, 0.0486), while parenchymal injury (excluding cranial neuropathies) correlated with volume and age (p = 0.0007, 0151). When complication risk in 276 of these meningioma patients with >2 yr follow-up were compared to 193 AVM patients in a multivariate model including dose and volume, the risk of symptomatic sequelae was 2.58 times higher for the AVM patients (p = 0.0415) (Table). Symptomatic sequelae developed in 21 patients for an actuarial rate of 6.6±1.4 % at 5 years. There were 15 cases of symptomatic parenchymal injury or edema (4.04±1.04%), including 3 patients requiring shunts, and 8 new cranial nerve deficits (2.69±0.95%). Asymptomatic post-radiosurgery imaging changes were identified on follow-up imaging in 15 patients (4.26±1.09%). Multivariate analysis significantly correlated symptomatic sequaelae with 12-Gy volume, isodose, and marginal dose (p = 0.0072, 0.005, 0.0486), while parenchymal injury (excluding cranial neuropathies) correlated with volume and age (p = 0.0007, 0151). When complication risk in 276 of these meningioma patients with >2 yr follow-up were compared to 193 AVM patients in a multivariate model including dose and volume, the risk of symptomatic sequelae was 2.58 times higher for the AVM patients (p = 0.0415) (Table). Conclusions
Read full abstract